SANJIT DUTTA: Open Payments
NPI 1881610038 · SPOKANE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$556 in 14 payments from 8 companies in 2025. Trend: 2023 $96 · 2024 $496 · 2025 $556
Food & beverage: $556
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $266 |
| Dexcom, Inc. | 1 | $93 |
| Lilly USA, LLC | 2 | $80 |
| Sumitomo Pharma America, Inc. | 2 | $42 |
| Otsuka America Pharmaceutical, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $8 |
Products named: Ozempic, Dexcom G6 Transmitter, GEMTESA, Wegovy, REXULTI, PREVNAR 20, MOUNJARO, XIFAXAN.
Industry payments across WA — which companies pay providers there.
